cytosine has been researched along with Retinitis in 19 studies
Retinitis: Inflammation of the RETINA. It is rarely limited to the retina, but is commonly associated with diseases of the choroid (CHORIORETINITIS) and of the OPTIC DISK (neuroretinitis).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Five AIDS patients with cytomegalovirus (CMV) retinitis who had received ganciclovir (GCV) therapy were followed with serial blood sampling to detectchanges both in CMV load and in the genetic composition of genes UL97 and UL54 whilst receiving cidofovir (CDV) therapy." | 7.70 | Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy. ( Bowen, EF; Cherrington, JM; Emery, VC; Griffiths, PD; Johnson, MA; Lamy, PD, 1999) |
| "(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC), a high-potency antiherpes and anticytomegalovirus (CMV) drug was evaluated in the treatment of experimental retinitis caused by preretinal herpes simplex virus (HSV-1) injection in rabbits." | 7.69 | Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. ( Bergeron-Lynn, G; Chandler, B; De Clercq, E; Flores-Aguilar, M; Freeman, WR; Huang, JS; Munguia, D; Vuong, C; Wiley, CA, 1994) |
| "The effect of liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC; cidofovir) was evaluated as prophylaxis in a rabbit model of experimentally induced retinitis caused by preretinal inoculation of herpes simplex virus type 1 (HSV-1)." | 7.69 | Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis. ( Assil, KK; Bergeron-Lynn, G; Besen, G; Connor, JD; De Clercq, E; Freeman, WR; Kuppermann, BD; Munguia, D; Pursley, M; Vuong, C; Wiley, CA, 1996) |
| "Five AIDS patients with cytomegalovirus (CMV) retinitis who had received ganciclovir (GCV) therapy were followed with serial blood sampling to detectchanges both in CMV load and in the genetic composition of genes UL97 and UL54 whilst receiving cidofovir (CDV) therapy." | 3.70 | Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy. ( Bowen, EF; Cherrington, JM; Emery, VC; Griffiths, PD; Johnson, MA; Lamy, PD, 1999) |
| "To evaluate(s)-1-(3-hydroxy-2-phosphonyl methoxypropyl) cytosine (HPMPC), a potent antiherpes and anticytomegalovirus drug, as a long-term treatment of experimental retinitis in rabbits." | 3.69 | Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC. ( Assil, KK; Bergeron-Lynn, G; Besen, G; De Clercq, E; Flores-Aguilar, M; Gangan, P; Kupperman, BD; Munguia, D; Pursley, M; Vuong, C, 1995) |
| "(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC), a high-potency antiherpes and anticytomegalovirus (CMV) drug was evaluated in the treatment of experimental retinitis caused by preretinal herpes simplex virus (HSV-1) injection in rabbits." | 3.69 | Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. ( Bergeron-Lynn, G; Chandler, B; De Clercq, E; Flores-Aguilar, M; Freeman, WR; Huang, JS; Munguia, D; Vuong, C; Wiley, CA, 1994) |
| "The effect of liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC; cidofovir) was evaluated as prophylaxis in a rabbit model of experimentally induced retinitis caused by preretinal inoculation of herpes simplex virus type 1 (HSV-1)." | 3.69 | Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis. ( Assil, KK; Bergeron-Lynn, G; Besen, G; Connor, JD; De Clercq, E; Freeman, WR; Kuppermann, BD; Munguia, D; Pursley, M; Vuong, C; Wiley, CA, 1996) |
| "To evaluate the decrease in intraocular pressure associated with cidofovir (1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate; HPMPC) intravitreal injections." | 3.69 | Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis. ( Arevalo, JF; Banker, AS; Berry, C; De Clercq, E; Freeman, WR; Ishimoto, B; Munguia, D; Ochabski, R; Rahhal, FM; Taskintuna, I, 1997) |
| "The initial and maintenance treatment of CMV retinitis must be individualized based on the characteristics of the lesions, including location and extent, specific patient factors, and characteristics of available therapies among others." | 1.30 | Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. ( Benson, CA; Deutsch, TA; Dieterich, DT; Drew, WL; Feinberg, J; Friedberg, DN; Griffiths, PD; Hardy, WD; Holland, GN; Jabs, DA; Jacobson, MA; Kessler, HA; Polis, MA; Powderly, WG; Spector, SA; Walmsley, S; Whitley, RJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 15 (78.95) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hubacek, P | 1 |
| Keslova, P | 1 |
| Formankova, R | 1 |
| Pochop, P | 1 |
| Cinek, O | 1 |
| Zajac, M | 1 |
| Lochmanova, J | 1 |
| Stary, J | 1 |
| Sedlacek, P | 1 |
| Zambarakji, HJ | 1 |
| Obi, AA | 1 |
| Mitchell, SM | 1 |
| Cheng, L | 1 |
| Hostetler, KY | 1 |
| Lee, J | 1 |
| Koh, HJ | 1 |
| Beadle, JR | 1 |
| Bessho, K | 1 |
| Toyoguchi, M | 1 |
| Aldern, K | 1 |
| Bovet, JM | 1 |
| Freeman, WR | 7 |
| Besen, G | 2 |
| Flores-Aguilar, M | 2 |
| Assil, KK | 2 |
| Kupperman, BD | 1 |
| Gangan, P | 1 |
| Pursley, M | 2 |
| Munguia, D | 5 |
| Vuong, C | 3 |
| De Clercq, E | 4 |
| Bergeron-Lynn, G | 3 |
| Huang, JS | 1 |
| Wiley, CA | 2 |
| Chandler, B | 1 |
| Kuppermann, BD | 1 |
| Connor, JD | 1 |
| Jabs, DA | 3 |
| Rahhal, FM | 3 |
| Arevalo, JF | 2 |
| Chavez de la Paz, E | 1 |
| Azen, SP | 1 |
| Cunningham, ET | 1 |
| Davis, JL | 1 |
| Taskintuna, I | 3 |
| Weinberg, DV | 1 |
| Feuer, WJ | 1 |
| Leonard, RE | 1 |
| Friedberg, DN | 2 |
| Blick, G | 1 |
| Garton, T | 1 |
| Hopkins, U | 1 |
| LaGravinese, L | 1 |
| Banker, AS | 1 |
| Ishimoto, B | 1 |
| Berry, C | 1 |
| Ochabski, R | 1 |
| Capparelli, EV | 1 |
| Cundy, KC | 1 |
| Whitley, RJ | 1 |
| Jacobson, MA | 1 |
| Holland, GN | 1 |
| Dieterich, DT | 1 |
| Hardy, WD | 1 |
| Polis, MA | 1 |
| Deutsch, TA | 1 |
| Feinberg, J | 1 |
| Spector, SA | 1 |
| Walmsley, S | 1 |
| Drew, WL | 1 |
| Powderly, WG | 1 |
| Griffiths, PD | 2 |
| Benson, CA | 1 |
| Kessler, HA | 1 |
| Bowen, EF | 1 |
| Cherrington, JM | 1 |
| Lamy, PD | 1 |
| Johnson, MA | 1 |
| Emery, VC | 1 |
| Cochereau, I | 1 |
| Doan, S | 1 |
| Diraison, MC | 1 |
| Mousalatti, H | 1 |
| Guvenisik, N | 1 |
| Ren, L | 1 |
| Hoang-Xuan, T | 1 |
| Robertson, DM | 1 |
| Riley, FC | 1 |
| Hermans, PE | 1 |
1 review available for cytosine and Retinitis
| Article | Year |
|---|---|
Cidofovir.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Organophosphonates; Organ | 1997 |
18 other studies available for cytosine and Retinitis
| Article | Year |
|---|---|
Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet.
Topics: Adolescent; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Encephalitis, Viral; | 2009 |
Successful treatment of varicella zoster virus retinitis with aggressive intravitreal and systemic antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Comb | 2002 |
Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Topics: Animals; Antiviral Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure | 2004 |
Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Electroretinography; Eye Inf | 1995 |
Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Ganciclovir; Herpes Simpl | 1994 |
Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Drug Carriers; Eye Infection | 1996 |
Treatment of cytomegalovirus retinitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cyto | 1996 |
Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infection | 1996 |
New therapies for cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cyto | 1997 |
Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis.
Topics: Adult; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovirus Infections; Cytosine; Female; Hu | 1997 |
Hypotony and visual loss with intravenous cidofovir treatment of cytomegalovirus retinitis.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Humans; Injections, Intrav | 1997 |
Successful use of cidofovir in treating AIDS-related cytomegalovirus retinitis, encephalitis, and esophagitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infection | 1997 |
Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anterior Chamber; Antiviral Agents; Aqueous Humor; Cidofo | 1997 |
Intravitreal and plasma cidofovir concentrations after intravitreal and intravenous administration in AIDS patients with cytomegalovirus retinitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cidofovir; Cohort Studies; Cytomegalovi | 1998 |
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytomegalovirus | 1998 |
Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapy.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus In | 1999 |
Uveitis in patients treated with intravenous cidofovir.
Topics: Adult; Anti-HIV Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; HIV Seropositivity; Humans; | 1999 |
Endogenous Candida oculomycosis. Report of two patients treated with flucytosine.
Topics: Aged; Antifungal Agents; Autopsy; Candida albicans; Candidiasis; Cytosine; Eye Diseases; Female; Flu | 1974 |